Mastoparan M Suppressed NLRP3 Inflammasome Activation by Inhibiting MAPK/NF-κB and Oxidative Stress in Gouty Arthritis
Yunbo Yan,Linqian Yu,Binyang Chen,Chang’an Cao,Hairong Zhao,Qiang Wang,De Xie,Yuemei Xi,Chenggui Zhang,Jidong Cheng
DOI: https://doi.org/10.2147/jir.s434587
IF: 4.5
2023-12-16
Journal of Inflammation Research
Abstract:Yunbo Yan, 1 Linqian Yu, 1 Binyang Chen, 1 Chang'an Cao, 1 Hairong Zhao, 1, 2 Qiang Wang, 1 De Xie, 1 Yuemei Xi, 1 Chenggui Zhang, 2 Jidong Cheng 1, 3 1 Department of Internal Medicine, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, People's Republic of China; 2 Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical R&D, Dali University, Dali, People's Republic of China; 3 Xiamen Key Laboratory of Translational Medicine for Nucleic Acid Metabolism and Regulation, Xiamen, People's Republic of China Correspondence: Jidong Cheng; Chenggui Zhang, Email ; Background: Gouty arthritis is characterized by the accumulation of monosodium urate crystals (MSU) in the synovial joints and surrounding tissues. Mastoparan M (Mast-M) is a biologically active peptide composed of 14 amino acids, extracted from wasp venom. This study aims to assess the impact of Mast-M on in vitro and in vivo gouty arthritis induced by lipolyaccharide (LPS) plus MSU crystal stimulation. Methods: PMA-differentiated THP-1 macrophages were pre-treated with Mast-M or left untreated, followed by stimulation with LPS and MSU crystals. Cell lysates were collected to assess the expression of the NLRP3 inflammasome, inflammatory signaling pathways, and oxidative stress. Furthermore, to evaluate the in vivo anti-inflammatory effect of Mast-M, an experimental acute gouty arthritis mouse model was established through intra-articular injection of MSU crystals. Results: Mast-M treatment demonstrated significant inhibition of the phosphorylation of MAPKs/NF-κB signaling pathways and reduction in oxidative stress expression in LPS and MSU-induced THP-1 macrophages. This resulted in the suppression of downstream NLRP3 inflammasome activation and IL-1β release. In vivo, Mast-M effectively attenuated the inflammation induced by MSU in mice with gouty arthritis. Specifically, Mast-M reduced swelling in the paws, inhibited the infiltration of neutrophils and macrophages into periarticular tissue, and decreased the activation of the NLRP3 inflammasome and IL-1β production. Conclusion: Mast-M significantly improves gouty arthritis, and its potential mechanism may be achieved by inhibiting the MAPK/NF-κB pathway and alleviating oxidative stress, thus suppressing the activation of NLRP3 inflammasomes. Keywords: Mastoparan M, NLRP3, MAPKs, NF-κB, oxidative stress, gout Gouty arthritis is a painful and inflammatory disease caused by the accumulation of MSU crystals in joints and surrounding tissues. 1 Numerous studies conducted in Asia, Europe, and North America have reported varying prevalence rates for gout, ranging from 0.6 to 2.9 cases per 1000 person-years. Among adults, the prevalence rates have been documented between 0.68% and 3.9%, with a notable increase in both incidence and prevalence over time. 2 Currently, the main drugs used to treat gouty arthritis are nonsteroidal anti-inflammatory drugs (NSAIDs), colchicine, and corticosteroids. 3 Due to the potential occurrence of adverse reactions and inconsistent treatment effectiveness associated with these medications, 3,4 there is an urgent need to develop new drugs for the treatment of gouty arthritis. Research findings have demonstrated the pivotal role of prolonged macrophage activation in the inflammatory response mechanism of gouty arthritis. 5 On one hand, macrophages are triggered by pathogens such as lipopolysaccharide (LPS). By activating signaling pathways such as mitogen-activated protein kinase (MAPK) and nuclear factor-kappa B (NF-κB), they mediate the expression of inflammatory genes such as TNF-α and cyclooxygenase-2 (COX-2). 6,7 On the other hand, macrophages engulf and internalize MSU crystals, triggering the activation of the NLRP3 inflammasome. 8 The activated NLRP3 inflammasome subsequently processes pro-IL-1β into active IL-1β, which plays a pivotal role in the inflammatory response and pain linked to gouty arthritis. 9 Additionally, recent research has reported that MSU crystals can also activate the NLRP3 inflammasome during gout by promoting excessive production of reactive oxygen species (ROS). 10–12 Mastoparan M (Mast-M) (C 70 H 131 N 19 O 15 ) (Figure 1A) is one of the major active components of wasp venom, accounting for approximately 70–80% of the crude extract. 13 Wasp venom is a complex mixture of various bioactive proteins and peptides, sharing similar pharmacological effects with bee venom. 14 Previous research has shown that wasp venom can allevia -Abstract Truncated-
immunology